<?xml version="1.0" encoding="UTF-8"?>
<p id="Par53">Regarding diagnosis and therapy of patients with endogenous Cushingâ€™s when extensive differential diagnostic testing is not feasible, it should be deferred. Salivary cortisol/cortisone tests should be avoided due to the potential of viral contamination and infection of laboratory staff. Treatment of potential co-morbidities (such as hypertension and diabetes) should be optimized and medical treatment must be initiated. Any form of treatment can be considered to switch to a block and replace regime (metyrapone or ketoconazole plus glucocorticoid) in order to ease the monitoring [
 <xref ref-type="bibr" rid="CR81">81</xref>].
</p>
